Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 3,961,602 7.100% | 3,961,602 (New Position) | Filing History |
| 2023-11-09 1:26 pm Sale | 2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Wellington Management Group LLP | 2,200,757 3.950% | -3,522,374 (-61.55%) | Filing History |
| 2023-04-10 09:06 am Purchase | 2023-03-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Wellington Management Group LLP | 5,723,131 10.350% | 260,474 (+4.77%) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,030,792 7.300% | -281,500 (-6.53%) | Filing History |
| 2023-02-14 2:50 pm Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,996,592 5.450% | 2,996,592 (New Position) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | T. Rowe Price Associates, Inc. | 1,480,194 2.700% | -1,398,520 (-48.58%) | Filing History |
| 2023-02-14 11:54 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Armistice Capital, LLC | 2,750,000 5.010% | 2,750,000 (New Position) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | The Vanguard Group | 5,335,076 9.710% | 266,486 (+5.26%) | Filing History |
| 2023-02-08 09:25 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 3,179,068 5.790% | 186,186 (+6.22%) | Filing History |
| 2023-02-06 2:43 pm Purchase | 2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Wellington Management Group LLP | 5,462,657 9.940% | 314,091 (+6.10%) | Filing History |
| 2023-01-25 10:36 am Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 4,768,874 8.700% | -735,122 (-13.36%) | Filing History |
| 2022-10-06 08:37 am Sale | 2022-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | JPMORGAN CHASE & CO JPM | 1,491,001 2.700% | -1,608,568 (-51.90%) | Filing History |
| 2022-09-12 11:13 am Sale | 2022-09-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 2,007,111 3.661% | -3,427,202 (-63.07%) | Filing History |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,503,996 10.100% | 95,460 (+1.76%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | T. Rowe Price Associates, Inc. | 2,878,714 5.300% | 2,878,714 (New Position) | Filing History |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,312,292 7.900% | 153,390 (+3.69%) | Filing History |
| 2022-02-09 4:36 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 2,992,882 5.510% | 2,992,882 (New Position) | Filing History |
| 2022-02-09 3:16 pm Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | The Vanguard Group | 5,068,590 9.330% | -415,984 (-7.58%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 5,434,313 10.006% | -2,199,667 (-28.81%) | Filing History |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Wellington Management Group LLP | 5,148,566 9.480% | -2,728,804 (-34.64%) | Filing History |